Exploring Iranian β-Thalassemia major patients’ perception of barriers and facilitators of adherence to treatment
A qualitative study
Keywords:
Medication adherence; Beta-Thalassemia; Patient compliance; Qualitative researchAbstract
Background: Despite the clinical importance of adherence to treatment in β-Thalassemia Major (β-TM) patients, poor adherence remains a prevalent and persistent problem in these patients. Objective: The aim of this study was to explore Iranian β-TM patients’ perception regarding the barriers and facilitators of adherence to their treatments. Methods: In this qualitative study, data were collected using purposeful sampling and semi-structured interviews with 18 β-TM patients, 3 family members and 5 healthcare professionals (total=26) in Sari, northern Iran, between August 2015 and May 2017. Data were analyzed using conventional content analysis with the support of MAXQDA software. All the interviews were transcribed verbatim. Data were coded and grouped under specific categories. Results: We identified and classified the perceived barriers of patients’ adherence to treatment into six main categories including: (I) long distance challenges, (II) delayed occurrence of complications, (III) fatigue of healthcare providers, (IV) staff workload, (V) insufficient follow-up of healthcare workers, and (VI) busy everyday life. Also, nine main categories emerged as facilitators including: (I) concern of appearance changing, (II) outcomes of treatment, (III) good awareness, (IV) parental monitoring, (V) fear of complications, (VI) social activity, (VII) marriage as a facilitator, (VIII) friendly interaction with the medical staff, and (IX) trusting the medical staff. Conclusion: Our findings provide a broad range of context-specific facilitators and barriers to treatment adherence perceived by Iranian β-TM patients. These factors improve our understanding of the complex and multifactorial nature of adherence to treatments. Health care providers can use these findings in designing and implementing appropriate interventions to promote β-TM patients’ adherence to treatment.References
Mednick L, Yu S, Trachtenberg F, Xu Y, Kleinert DA, Giardina PJ, et al. Symptoms of depression and
anxiety in patients with thalassemia: prevalence and correlates in the thalassemia longitudinal cohort. Am J
Hematol. 2010; 85(10): 802-5. doi: 10.1002/ajh.21826. PMID: 20806230.
Darvishi Khezri H, Emami Zeydi A, Sharifi H, Jalali H. Is Vitamin C Supplementation in Patients with
beta-Thalassemia Major Beneficial or Detrimental? Hemoglobin. 2016; 40(4): 293-4. doi:
1080/03630269.2016.1190373. PMID: 27492769.
Dehshal MH. Addressing adherence to treatment: a longstanding concern. The patients’ perspective.
Thalassemia Reports. 2014; 4(3). doi: 10.1080/03630269.2016.1190373. PMID: 27492769.
Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of
research. A comprehensive review. J Clin Pharm Ther. 2001; 26(5): 331-42. doi: 10.1046/j.1365- 2710.2001.00363.x. PMID: 11679023.
Pedram M, Zandian K, Keikhaie B, Akramipour R, Hashemi A, Ghahfarokhi FK, et al. A report on
chelating therapy and patient compliance by determination of serum ferritin levels in 243 thalassemia major
patients. Iranian J Pediatr Soc. 2010; 2(2): 65-9.
Ragab LA, Hamdy MM, Shaheen IA, Yassin RN. Blood transfusion among thalassemia patients: A single
Egyptian center experience. Asian J Transfus Sci. 2013; 7(1): 33-6. doi: 10.4103/0973-6247.106728.
PMID: 23559762.
Coifman KG, Ross GS, Kleinert D, Giardina P. Negative affect differentiation and adherence during
treatment for thalassemia. Int J Behav Med. 2014; 21(1): 160-8. PMID: 23086716. doi: 10.1007/s12529- 012-9277-7.
Pages-Puigdemont N, Mangues MA, Masip M, Gabriele G, Fernandez-Maldonado L, Blancafort S, et al.
Patients' Perspective of Medication Adherence in Chronic Conditions: A Qualitative Study. Adv Ther.
; 33(10): 1740-54. PMID: 27503082. doi: 10.1007/s12325-016-0394-6.
) Lehane E, McCarthy G. Intentional and unintentional medication non-adherence: a comprehensive
framework for clinical research and practice? A discussion paper. Int J Nurs Stud. 2007; 44(8): 1468-77.
doi: 10.1016/j.ijnurstu.2006.07.010. PMID: 16973166.
Ward A, Caro JJ, Green TC, Huybrechts K, Arana A, Wait S, et al. An international survey of patients with
thalassemia major and their views about sustaining life-long desferrioxamine use. BMC Clin Pharmacol.
; 2: 3. doi: 10.1186/1472-6904-2-3. PMID: 12015817.
Morris LS, Schulz RM. Medication compliance: the patient's perspective. Clin Ther. 1993; 15(3): 593-606.
PMID: 8364951.
Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment
in chronic physical illness. J Psychosom Res. 1999; 47(6): 555-67. doi: 10.1016/S0022-3999(99)00057-4.
PMID: 10661603.
Al-Busaidi ZQ. Qualitative research and its uses in health care. Sultan Qaboos Univ Med J. 2008; 8(1): 11- 9. PMID: 21654952.
Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005; 15(9):
-88. doi: 10.1177/1049732305276687. PMID: 16204405.
Lincoln YS, Guba EG. But is it rigorous? Trustworthiness and authenticity in naturalistic evaluation. New
Directions for Program Evaluation. 1986; 1986(30): 73-84. doi: 10.1002/ev.1427.
Shaligram D, Girimaji SC, Chaturvedi SK. Psychological problems and quality of life in children with
thalassemia. Indian J Pediatr. 2007; 74(8): 727-30. doi: 10.1007/s12098-007-0127-6. PMID: 17785893.
Zamani R, Khazaei S, Rezaeian S. Survival analysis and its associated factors of Beta thalassemia major in
hamadan province. Iran J Med Sci. 2015; 40(3): 233-9. PMID: 25999623.
Ganzella M, Zago MM. The experience of thalassemic adults with their treatment. Rev Lat Am
Enfermagem. 2011; 19(4): 968-76. doi: 10.1590/S0104-11692011000400016. PMID: 21876950.
Borgna-Pignatti C, Gamberini MR. Complications of thalassemia major and their treatment. Expert Rev
Hematol. 2011; 4(3): 353-66. doi: 10.1586/ehm.11.29. PMID: 21668399.
Olivieri NF. Adherence to deferoxamine therapy: heeding Hippocrates and Osler. Am J Hematol. 2004;
(4): 415-6. doi: 10.1002/ajh.20102. PMID: 15282681.
Sapountzi-Krepia D, Roupa Z, Gourni M, Mastorakou F, Vojiatzi E, Kouyioumtzi A, et al. A qualitative
study on the experiences of mothers caring for their children with thalassemia in Athens, Greece. J Pediatr
Nurs. 2006; 21(2): 142-52. doi: 10.1016/j.pedn.2005.06.017. PMID: 16545674.
Miri-Moghaddam E, Naderi M, Izadi S, Mashhadi M. Causes of new cases of major thalassemia in sistan
and balouchistan province in South-East of iran. Iran J Public Health. 2012; 41(11): 67-71. PMID:
Karimi Moonaghi H, Emami Zeydi A, Mirhaghi A. Patient education among nurses: bringing evidence into
clinical applicability in Iran. Invest Educ Enferm. 2016; 34(1): 137-51. doi: 10.17533/udea.iee.v34n1a16.
PMID: 28569983.
van Ryn M, Burke J. The effect of patient race and socio-economic status on physicians' perceptions of
patients. Soc Sci Med. 2000; 50(6): 813-28. doi: 10.1016/S0277-9536(99)00338-X. PMID: 10695979.
M'Imunya JM, Kredo T, Volmink J. Patient education and counselling for promoting adherence to
treatment for tuberculosis. Cochrane Database Syst Rev. 2012(5):Cd006591. doi:
1002/14651858.CD006591.pub2. PMID: 22592714.
Loizou C, Phellas C, Beck S, Karekla M, Talias M, Christou S, et al. How Life Would Be Without
Thalassaemia: Patients' Perceptions. The Cyprus Review. 2016; 28(1): 33.
Wahab IA, Naznin M, Nora MZ, Suzanah AR, Zulaiho M, Faszrul AR, et al. Thalassaemia: a study on the
perception of patients and family members. Med J Malaysia. 2011; 66(4): 326-34. PMID: 22299552.
Pouraboli B, Abedi HA, Abbaszadeh A, Kazemi M. Living in a misty marsh: A qualitative study on the
experiences of self-care suffering of patients with thalassemia. Iran J Nurs Midwifery Res. 2014; 19(7
Suppl 1):S77-82. PMID: 25949257, PMCID: PMC4402994.
Rumsey N, Harcourt D. Visible difference amongst children and adolescents: issues and interventions. Dev
Neurorehabil. 2007; 10(2): 113-23. doi: 10.1080/13638490701217396. PMID: 17687984.
DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes:
a meta-analysis. Med Care. 2002; 40(9): 794-811. doi: 10.1097/01.MLR.0000024612.61915.2D. PMID:
Lee YL, Lin DT, Tsai SF. Disease knowledge and treatment adherence among patients with thalassemia
major and their mothers in Taiwan. J Clin Nurs. 2009; 18(4): 529-38. doi: 10.1111/j.1365- 2702.2007.02150.x. PMID: 19192002.
Al-Kloub MI, A Bed MA, Al Khawaldeh OA, Al Tawarah YM, Froelicher ES. Predictors of non-adherence
to follow-up visits and deferasirox chelation therapy among Jordanian adolescents with Thalassemia major.
Pediatr Hematol Oncol. 2014; 31(7): 624-37. doi: 10.3109/08880018.2014.939792. PMID: 25116329.
Ellis DA, Podolski CL, Frey M, Naar-King S, Wang B, Moltz K. The role of parental monitoring in
adolescent health outcomes: impact on regimen adherence in youth with type 1 diabetes. J Pediatr Psychol.
; 32(8): 907-17. doi: 10.1093/jpepsy/jsm009. PMID: 17426045.
Wiebe DJ, Berg CA, Korbel C, Palmer DL, Beveridge RM, Upchurch R, et al. Children's appraisals of
maternal involvement in coping with diabetes: enhancing our understanding of adherence, metabolic
control, and quality of life across adolescence. J Pediatr Psychol. 2005; 30(2): 167-78. doi:
1093/jpepsy/jsi004. PMID: 15681311.
Michaud PA, Suris JC, Viner R. The adolescent with a chronic condition. Part II: healthcare provision.
Arch Dis Child. 2004; 89(10): 943-9. doi: 10.1136/adc.2003.045377. PMID: 15383439.
Jack K, McLean SM, Moffett JK, Gardiner E. Barriers to treatment adherence in physiotherapy outpatient
clinics: a systematic review. Man Ther. 2010; 15(3): 220-8. PMID: 20163979. doi:
1016/j.math.2009.12.004.
Nachega JB, Uthman OA, Peltzer K, Richardson LA, Mills EJ, Amekudzi K, et al. Association between
antiretroviral therapy adherence and employment status: systematic review and meta-analysis. Bull World
Health Organ. 2015; 93(1): 29-41. doi: 10.2471/BLT.14.138149. PMID: 25558105.
Herbig B, Dragano N, Angerer P. Health in the long-term unemployed. Dtsch Arztebl Int. 2013; 110(23- 24): 413-9. doi: 10.3238/arztebl.2013.0413. PMID: 23837086.
Simba DO, Kakoko D. Primacy of effective communication and its influence on adherence to artemetherlumefantrine treatment for children under five years of age: a qualitative study. BMC Health Serv Res.
; 12: 146. doi: 10.1186/1472-6963-12-146. PMID: 22682180.
Birkhauer J, Gaab J, Kossowsky J, Hasler S, Krummenacher P, Werner C, et al. Trust in the health care
professional and health outcome: A meta-analysis. PLoS One. 2017; 12(2): e0170988. doi:
1371/journal.pone.0170988. PMID: 28170443.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
